MSB 1.86% $1.32 mesoblast limited

MSB Trading 2020 - a new dawn, page-3649

  1. 2,483 Posts.
    lightbulb Created with Sketch. 275
    essentially going to be a question of whether the perceived outcome benefits outweigh the perceived input risks.

    i'm not so sure they do. Others have alluded to notion that the FDA have approved treatments with similar risk in the past, but i personally don't know of any such precedent. Then again, I'll be the first to admit i'm not an expert on previous FDA decisions.

    If the FDA do approve (and there is no similar/alike decision for input risk - outcome benefit cases) then it may set a dangerous precedent for them. And i doubt they'd be willing to go out on a limb if there are any other notable risks (eg. previous adult placebo trial outcomes...) .

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.32
Change
-0.025(1.86%)
Mkt cap ! $1.507B
Open High Low Value Volume
$1.35 $1.35 $1.31 $2.699M 2.040M

Buyers (Bids)

No. Vol. Price($)
2 34995 $1.32
 

Sellers (Offers)

Price($) Vol. No.
$1.33 10374 2
View Market Depth
Last trade - 16.10pm 31/10/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.